Journal
SWISS MEDICAL WEEKLY
Volume 142, Issue -, Pages -Publisher
E M H SWISS MEDICAL PUBLISHERS LTD
DOI: 10.4414/smw.2012.13559
Keywords
transplacental transfer; nanoparticles; uptake mechanisms
Categories
Funding
- Swiss National Science Foundation [4064-131232]
- European Union [FP7/2007-2013, 263215]
Ask authors/readers for more resources
Exposure of pregnant women and their unborn children to engineered nanoparticles (NPs) is not yet of major public concern. However, this may soon change in light of the ever-increasing production of NPs and the continuous appearance of novel NP-containing consumer products. However, NPs may not only pose risks to exposed individuals; they offer major potential for the development of novel therapeutic strategies to treat specifically either the mother or the developing foetus. Hence there is every reason to explore the transplacental transfer of engineered NPs in more detail, and to find answers to the vast number of open questions in this fascinating field of research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available